article thumbnail

STAT+: Pharmalittle: Pfizer and Novo disclose upbeat data on oral weight loss drugs; PBM trade group blasts House committee over hearing

STAT

A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus. Meanwhile, an oral drug from Pfizer causes a similar amount of weight loss as Ozempic, according to results from a Phase 2 clinical trial, CNBC says. Walgreens asked a U.S. Walgreens asked a U.S.

article thumbnail

The Prescription-Discount Advantage For Self-Insured Companies. And Their Employees.

Proxsys Rx

The skyrocketing costs of prescription drugs It’s no secret that prescription drug prices are rising faster than the rate of inflation, forcing employers to shift more of their prescription benefit costs to their employees and families. This usually means higher deductibles, higher co-pays, and lower morale among employees.

article thumbnail

ProxsysRx’s MedServRx: The Prescription-Drug Advantage For Patients And Their Providers

Proxsys Rx

The growing problem of prescription non-adherence According to a study published in the Annals of Internal Medicine, nearly 1/3 of all prescriptions are never filled by patients, and up to half of medications for chronic conditions like diabetes and hypertension are never taken.